Related Experiment Video
Updated: Apr 26, 2026
08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
11.9K
Echinocandins--new antifungal agents
Summary
Echinocandins are a new class of antifungal drugs that target the fungal cell wall. Semisynthetic echinocandins offer improved safety and efficacy for treating invasive fungal infections.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Invasive fungal infections pose a significant clinical challenge.
- The development of novel antifungal agents is crucial.
Purpose of the Study:
- To review the class of echinodandin antifungal agents.
- To highlight the advantages of semisynthetic echinocandins.
Main Methods:
- Review of existing literature on echinocandins.
- Analysis of chemical properties and clinical utility.
Main Results:
- Echinocandins inhibit beta-1,3-glucan-synthase, essential for fungal cell wall integrity.
- Semisynthetic echinocandins demonstrate low toxicity, high water-solubility, and potent activity against Candida, Aspergillus, and Pneumocystis.
- Limited in vitro activity against Cryptococcus neoformans was noted.
Conclusions:
- Semisynthetic echinocandins represent a significant advancement in antifungal therapy.
- Agents like caspofungin, micafungin, and anidulafungin offer favorable pharmacokinetics and safety profiles for once-daily administration.
Related Concept Videos
01:15Antifungal Agents
114
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
114
01:15Anthelminthic Agents
101
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
101
01:25Inhibitors of Bacterial Protein Synthesis
99
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
99
01:28Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:28Fungal Phylum Ascomycota
2.4K
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K